Skip to content

Yoga for Breast Cancer

A Randomized Study of the Effect of Yoga in Patients With Breast Cancer Receiving Radiation Therapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01985945
Enrollment
70
Registered
2013-11-18
Start date
2013-03-31
Completion date
2015-12-31
Last updated
2020-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women With Stage I or II Breast Cancer Undergoing Active Radiation Therapy

Brief summary

The purpose of this study is to examine the use of Eischens yoga for 8 weeks in one cohort of 20 women with stage I and II breast cancer receiving radiation therapy treatment, while a second cohort of the same type of and number of patients who, instead of yoga will receive standard supportive therapy, Questionnaire measuring cancer-related quality of life (FACT-G instrument) and fatigue (Brief Fatique Inventory) will be given to patients at several points.

Interventions

OTHERYoga

Sponsors

Abramson Cancer Center at Penn Medicine
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Stage I and II breast cancer patients undergoing active radiation therapy * Above the age of 18 * Must sign informed consent form * Must speak English * Only women are eligible

Exclusion criteria

* Patients with medical restrictions that may interfere with yoga participation per their physicians' decision * Those who have smoked in the last 6 months because smoking can interfere with the breathing and relaxation techniques of yoga. * Those who have regularly taken yoga in the last 6 months, because they would not come to the intervention with the same baseline as other participants.

Design outcomes

Primary

MeasureTime frame
Number of Adverse EventsOne Year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026